Clik here to view.
Biotech IPO Update for May 18th, 2011
There are now eight biotech IPOs for 2011, bringing the total for the recent US IPO window to 28. Post-IPO performance is finally picking up with the median return at +14% for these 28 IPOs. Advanced...
View ArticleClik here to view.
Data Protection, Trans Pacific Partnership, and the US-Jordan FTA (Post 2 of 2)
This post is a continuation of a previous post: Data Protection, the Trans Pacific Partnership, and the US-Jordan FTA (Post 1 of 2). 4. Oxfam criticizes pharmaceutical innovators for not making all of...
View ArticleClik here to view.
BioManufacturers Increasing Budgets for New Technologies
By Eric Langer, Managing Partner, BioPlan Associates, Inc. Two-thirds Spending more for Improved Productivity Almost two-thirds (64.2 percent) of biomanufacturers will increase their budgets for new...
View Article2012 BIO Investor Forum: Discovery Track Snapshot
BIO’s 11th Annual BIO Investor Forum is just around the corner – it will be held October 9-10, 2012 at the Palace Hotel in San Francisco, CA. The forum, or BIF as we call it around here, is an...
View ArticleClik here to view.
Nationwide Track and Trace System is Urgently Needed
Today’s pharmaceutical distribution supply chain is governed largely by a patchwork of state laws and regulations that allows criminals to enter markets with the lowest safety requirements to inject...
View Article4 Benefits of Plant-Made Pharmaceuticals
For centuries, plants have served as a natural source of treatments and therapies. New advances in biotechnology make it possible to turn plants into “factories” that produce therapeutic proteins for...
View ArticleClik here to view.
Indian Patents Ensure Wide Access to Drugs, Without Raising Prices
Two recent studies on Indian drugs have shown that patent protection does not dramatically increase prices, but does ensure widespread access to life saving therapeutics. This research confirms that a...
View Article
